Hepatitis B Virus (HBV)

Tag: HMG-CoA reductase inhibitors (Page 6)

Atorvastatin calcium: A new HMG-CoA reductase inhibitor(3)

Elevated plasma concentrations of the structural protein of LDL and very low density lipoprotein (VLDL) particles, apoli-poprotein B (apo B), have also been positively correlated with CAD , and high density lipoprotein cholesterol (HDL-C) level is inversely correlated with CAD . The data supporting an association of elevated triglyceride levels as an independent risk factor […]

Atorvastatin calcium: A new HMG-CoA reductase inhibitor(2) / asthma inhalers

Epidemiological evidence from the Multiple Risk Factor Intervention Trial (MRFIT) suggests that levels of serum total cholesterol are directly related to the rate of CAD . In addition, LDL-C is recognized to be the major atherogenic lipoprotein fraction in the development of atherosclerosis , and LDL-C reduction is associated with both decreased progression and increased […]

Atorvastatin calcium: A new HMG-CoA reductase inhibitor(1)

Cardiovascular diseases remain the leading cause of death in Canada; 40% of all deaths are attributed to this disease category . Coronary artery disease (CAD) and cerebrovascular disease are the major components of cardiovascular disease. Although Canadian rates of CAD have fallen over the past few decades, they remain higher than the average in many […]